Proteomics

Dataset Information

0

Polygonum perfoliatum L. ameliorates NAFLD by promoting PPARs/CPT1A/CPT2-mediated fatty acid β-oxidation


ABSTRACT: We performed a label-free quantitative proteomic profiling to determine the effect of Polygonum perfoliatum L. treated the proteomics profile of liver tissue and identified activated PPARs/CPT1A/CPT2-mediated hepatic fatty acid β oxidation process was significantly altered

ORGANISM(S): Mus Musculus

SUBMITTER: Xiaoni Kong  

PROVIDER: PXD033219 | iProX | Mon Feb 05 00:00:00 GMT 2024

REPOSITORIES: iProX

altmetric image

Publications

Quantitative proteomics reveals <i>Polygonum perfoliatum L.</i> ameliorates hepatic steatosis by promoting PPARs/CPT1A/CPT2-mediated fatty acid β-oxidation.

Liu Guanjie G   Chang Ling L   Qian Yihan Y   Lin Jiacheng J   Shang Zhi Z   Xu Min M   Wang Fang F   Sun Xuehua X   Jiang Yun Y   Gao Yueqiu Y   Kong Xiaoni X  

Frontiers in pharmacology 20230323


Non-alcoholic fatty liver disease (NAFLD) is a predominant contributor to end-stage liver disease in the forthcoming decades. <i>Polygonum perfoliatum L.</i> (PPL) is an herbal medicine with anti-lipid peroxidation and anti-inflammatory properties. However, detailed hepatoprotective effects of PPL against NAFLD and its underlying mechanisms are not fully understood. Here, we found that PPL protects against high fat diet (HFD)-induced hepatic steatosis, lipid peroxidation, and glucose-lipid metab  ...[more]

Similar Datasets

2016-05-10 | GSE77652 | GEO
2019-10-17 | BIOMD0000000835 | BioModels
2018-09-12 | E-MTAB-6595 | biostudies-arrayexpress
2003-07-16 | GSE474 | GEO
2014-01-15 | BIOMD0000000506 | BioModels
2014-01-15 | BIOMD0000000505 | BioModels
| PRJNA742022 | ENA
2019-08-25 | GSE135595 | GEO
2018-04-14 | GSE113032 | GEO
2012-12-04 | E-GEOD-42693 | biostudies-arrayexpress